Estradiol Transdermal (Estradiol)
Estrogen class · 0 generic manufacturers · 0 ANDAs filed at FDA.
Questions a plan sponsor actually asks.
What is Estradiol Transdermal used for?
Estradiol Transdermal is tracked in Medicare Part D. Specific indication information is not available in our current dataset.
Is there a generic for Estradiol Transdermal?
No. Estradiol Transdermal is brand-only with no generic equivalents currently in market.
How much does my plan pay for Estradiol Transdermal?
Across 329 Part D plans, Estradiol Transdermal averages $0.801/unit (NADAC). Lowest available: $0.592/unit. Highest in distribution: $0.967/unit.
Is Estradiol Transdermal on the FDA shortage list?
No. Estradiol Transdermal is not currently on the FDA Drug Shortage Database.
4 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (5 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.